PI3K
PI3K (phosphatidylinositol-4,5-bisphosphate 3-kinase) is a family of enzymes involved in cellular functions such as cell growth, proliferation, differentiation, motility, survival and intracellular trafficking, which in turn are involved in cancer.
PI3K 相关产品(222)
- GC19283PF-04979064CAS: 1220699-06-8纯度: >99.50%
PF-04979064 是一种有效的选择性 PI3K/mTOR 双激酶抑制剂,对 PI3Kα 和 mTOR 的 Kis 分别为 0.13 nM 和 1.42 nM。
- GC19540α-Linolenic AcidCAS: 463-40-1纯度: >98.00% / >99.00% / >99.50%
An essential ω-3 polyunsaturated fatty acid
- GC25913Selective PI3Kδ Inhibitor 1 (compound 7n)CAS: 2088525-31-7
Selective PI3Kδ Inhibitor 1 (compound 7n) is an inhibitor of PI3Kδ with an IC50 of 0.9 nM and >1000-fold selectivity against other class I PI3K isoforms [PI3K α/γ/β=3670/1460/21300 nM].
- GC26044VPS34 inhibitor 1 (Compound 19)CAS: 1383716-46-8
VPS34 inhibitor 1 (Compound 19, PIK-III analogue) is a potent and selective inhibitor of VPS34 with an IC50 of 15 nM.
- GC30156Brevianamide F (Cyclo(L-Pro-L-Trp))CAS: 38136-70-8纯度: >99.00%
An alkaloid with diverse biological activities
- GC31666Seletalisib (UCB5857)CAS: 1362850-20-1纯度: >98.50%
Seletalisib (UCB-5857) is a novel small-molecule inhibitor of PI3Kδ with an IC50 value of 12 nM and shows significant selectivity to PI3Kδ with respect to the other class I PI3K isoforms (between 24- and 303-fold).
- GC31751PI3Kδ-IN-2CAS: 1702816-75-8纯度: >99.50%
PI3Kδ-IN-2 (YY-20394) 是 PI3Kδ 的强效、口服生物利用度和选择性抑制剂;提取自专利WO 2015055071 A1,化合物10; IC50 为 6.4 nM。
- GC32710GDC-0077 (RG6114)CAS: 2060571-02-8纯度: >98.00% / >99.00%
GDC-0077 (RG6114)是一种高效且选择性的PI3Kα抑制剂,IC 50 值为0.038nM。
- GC32828Tenalisib (RP6530)CAS: 1639417-53-0纯度: >98.50%
Tenalisib (RP6530) is a potent and selective dual PI3Kδ/γ inhibitor with IC50 values of 24.5 nM and 33.2 nM for PI3Kδ and PI3Kγ, respectively. Its selectivity over α and β isoforms are more than 300-fold and 100-fold, respectively.
- GC32847PI4KIIIbeta-IN-9CAS: 1429624-84-9纯度: >99.00%
PI4KIIIbeta-IN-9是一种有效的PI4KIIIβ抑制剂,IC50为7nM。PI4KIIIbeta-IN-9也抑制PI3Kδ和PI3Kγ,IC50分别为152nM和1046nM。
- GC32916Parsaclisib (INCB050465)CAS: 1426698-88-5纯度: >99.00%
Parsaclisib (INCB050465, INCB-50465, IBI376) is a potent and highly selective PI3Kδ(PI3K delta) inhibitor with an IC50 of 1 nM at 1 mM ATP in biochemical assay and approximately 20,000-fold selectivity for PI3Kα, PI3Kβ, PI3Kγ and 57 other kinases.
- GC32932Vps34-IN-2CAS: 1523404-29-6纯度: >99.50%
Vps34-IN-2是一种新型的,有效且有选择性的Vps34抑制剂,在Vps34酶促测定和GFP-FYVE细胞测定中的IC50值分别为2和82nM。
- GC33145BEBT-908 (PI3Kα inhibitor 1)CAS: 1235449-52-1纯度: >99.00%
BEBT-908 (PI3Kα inhibitor 1) (PI3Kα inhibitor 1) 是一种选择性 PI3Kα从专利US/20120088764A1中提取的抑制剂化合物243,IC50<0.1 μM, PI3Kα抑制剂 1 还抑制 HDAC (0.1 μM≤IC50≤1 μM)。
- GC33162Duvelisib R enantiomer (IPI-145 R enantiomer)CAS: 1261590-48-0
Duvelisib R 对映异构体是一种 PI3K 抑制剂,是 Duvelisib 活性较低的对映异构体。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC19283 | PF-04979064 | 1220699-06-8 | >99.50% | |
PF-04979064 是一种有效的选择性 PI3K/mTOR 双激酶抑制剂,对 PI3Kα 和 mTOR 的 Kis 分别为 0.13 nM 和 1.42 nM。 | ||||
| GC19300 | PQR309 | 1225037-39-7 | >98.50% | |
PQR309 是一种有效的脑渗透性口服生物利用度泛 I 类 PI3K/mTOR 抑制剂,对 PI3Kα、PI3Kδ、PI3Kβ、PI3Kγ 和 mTOR 的 IC50 分别为 33nM、451nM、661nM、708nM 和 89nM .PQR309 在人脑胶质瘤细胞中通过抑制增殖、诱导细胞凋亡、诱导 G1 细胞周期停滞、抑制侵袭和迁移等方式发挥抗肿瘤作用。 | ||||
| GC19328 | SF2523 | 1174428-47-7 | - | |
A dual inhibitor of PI3K and BRD4 | ||||
| GC19355 | Umbralisib | 1532533-67-7 | >98.50% | |
A PI3K p110δ inhibitor | ||||
| GC19411 | IITZ-01 | 1807988-47-1 | >99.00% | |
IITZ-01 是一种有效的溶酶体自噬抑制剂,具有单剂抗肿瘤活性,对 PI3Kγ 的 IC50 为 2.62 μM。 | ||||
| GC19471 | Leniolisib | 1354690-24-6 | >99.00% | |
An inhibitor of PI3Kδ | ||||
| GC19540 | α-Linolenic Acid | 463-40-1 | >98.00% / >99.00% / >99.50% | |
An essential ω-3 polyunsaturated fatty acid | ||||
| GC19921 | Phenylarsine Oxide | 637-03-6 | >98.00% | |
An organoarsenic compound | ||||
| GC25913 | Selective PI3Kδ Inhibitor 1 (compound 7n) | 2088525-31-7 | - | |
Selective PI3Kδ Inhibitor 1 (compound 7n) is an inhibitor of PI3Kδ with an IC50 of 0.9 nM and >1000-fold selectivity against other class I PI3K isoforms [PI3K α/γ/β=3670/1460/21300 nM]. | ||||
| GC26044 | VPS34 inhibitor 1 (Compound 19) | 1383716-46-8 | - | |
VPS34 inhibitor 1 (Compound 19, PIK-III analogue) is a potent and selective inhibitor of VPS34 with an IC50 of 15 nM. | ||||
| GC30156 | Brevianamide F (Cyclo(L-Pro-L-Trp)) | 38136-70-8 | >99.00% | |
An alkaloid with diverse biological activities | ||||
| GC30884 | LX2343 | 333745-53-2 | >99.50% | |
An inhibitor of BACE1 and PI3K | ||||
| GC31666 | Seletalisib (UCB5857) | 1362850-20-1 | >98.50% | |
Seletalisib (UCB-5857) is a novel small-molecule inhibitor of PI3Kδ with an IC50 value of 12 nM and shows significant selectivity to PI3Kδ with respect to the other class I PI3K isoforms (between 24- and 303-fold). | ||||
| GC31751 | PI3Kδ-IN-2 | 1702816-75-8 | >99.50% | |
PI3Kδ-IN-2 (YY-20394) 是 PI3Kδ 的强效、口服生物利用度和选择性抑制剂;提取自专利WO 2015055071 A1,化合物10; IC50 为 6.4 nM。 | ||||
| GC31756 | IPI-3063 | 1425043-73-7 | >98.50% | |
IPI-3063 is a potent and selective p110δ inhibitor with biochemical IC50 of 2.5?±?1.2 nM and IC50 values for the other class I PI3K isoforms (p110α, p110β, p110γ) are at least 400-fold higher. | ||||
| GC32710 | GDC-0077 (RG6114) | 2060571-02-8 | >98.00% / >99.00% | |
GDC-0077 (RG6114)是一种高效且选择性的PI3Kα抑制剂,IC 50 值为0.038nM。 | ||||
| GC32828 | Tenalisib (RP6530) | 1639417-53-0 | >98.50% | |
Tenalisib (RP6530) is a potent and selective dual PI3Kδ/γ inhibitor with IC50 values of 24.5 nM and 33.2 nM for PI3Kδ and PI3Kγ, respectively. Its selectivity over α and β isoforms are more than 300-fold and 100-fold, respectively. | ||||
| GC32847 | PI4KIIIbeta-IN-9 | 1429624-84-9 | >99.00% | |
PI4KIIIbeta-IN-9是一种有效的PI4KIIIβ抑制剂,IC50为7nM。PI4KIIIbeta-IN-9也抑制PI3Kδ和PI3Kγ,IC50分别为152nM和1046nM。 | ||||
| GC32916 | Parsaclisib (INCB050465) | 1426698-88-5 | >99.00% | |
Parsaclisib (INCB050465, INCB-50465, IBI376) is a potent and highly selective PI3Kδ(PI3K delta) inhibitor with an IC50 of 1 nM at 1 mM ATP in biochemical assay and approximately 20,000-fold selectivity for PI3Kα, PI3Kβ, PI3Kγ and 57 other kinases. | ||||
| GC32932 | Vps34-IN-2 | 1523404-29-6 | >99.50% | |
Vps34-IN-2是一种新型的,有效且有选择性的Vps34抑制剂,在Vps34酶促测定和GFP-FYVE细胞测定中的IC50值分别为2和82nM。 | ||||
| GC33014 | NSC781406 | 1676893-24-5 | >99.50% | |
A dual inhibitor of PI3K and mTOR | ||||
| GC33130 | Recilisib (Ex-RAD) | 334969-03-8 | >98.00% | |
Recilisib (Ex-RAD)是一种辐射防护剂,可以激活细胞中AKT和PI3K的活性。 | ||||
| GC33145 | BEBT-908 (PI3Kα inhibitor 1) | 1235449-52-1 | >99.00% | |
BEBT-908 (PI3Kα inhibitor 1) (PI3Kα inhibitor 1) 是一种选择性 PI3Kα从专利US/20120088764A1中提取的抑制剂化合物243,IC50<0.1 μM, PI3Kα抑制剂 1 还抑制 HDAC (0.1 μM≤IC50≤1 μM)。 | ||||
| GC33162 | Duvelisib R enantiomer (IPI-145 R enantiomer) | 1261590-48-0 | - | |
Duvelisib R 对映异构体是一种 PI3K 抑制剂,是 Duvelisib 活性较低的对映异构体。 | ||||
